LLY

939

-4.36%↓

JNJ

240.93

-0.32%↓

ABBV

222.23

+0.48%↑

NVS

154.79

+0.41%↑

AZN

191.77

+0.09%↑

LLY

939

-4.36%↓

JNJ

240.93

-0.32%↓

ABBV

222.23

+0.48%↑

NVS

154.79

+0.41%↑

AZN

191.77

+0.09%↑

LLY

939

-4.36%↓

JNJ

240.93

-0.32%↓

ABBV

222.23

+0.48%↑

NVS

154.79

+0.41%↑

AZN

191.77

+0.09%↑

LLY

939

-4.36%↓

JNJ

240.93

-0.32%↓

ABBV

222.23

+0.48%↑

NVS

154.79

+0.41%↑

AZN

191.77

+0.09%↑

LLY

939

-4.36%↓

JNJ

240.93

-0.32%↓

ABBV

222.23

+0.48%↑

NVS

154.79

+0.41%↑

AZN

191.77

+0.09%↑

Search

Odonate Therapeutics Inc

Fermé

0

Résumé

Variation du prix de l'action

24h

Actuel

Min

Max

Chiffres clés

By Trading Economics

Odonate Therapeutics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

16 mars 2026, 21:37 UTC

Acquisitions, Fusions, Rachats

Lensar and Alcon Agree to Terminate Merger

16 mars 2026, 19:06 UTC

Principaux Événements d'Actualité

Mideast Loses 12 Million Boe/d Following Hormuz Closure: Rystad -- OPIS

16 mars 2026, 17:44 UTC

Acquisitions, Fusions, Rachats

Novartis Issues Debt Offering to Help Fund $12 Billion Acquisition of Avidity Biosciences

16 mars 2026, 23:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 mars 2026, 23:46 UTC

Market Talk

Nikkei May Rise After Oil Prices Decline -- Market Talk

16 mars 2026, 23:37 UTC

Market Talk

Gold Edges Higher on Possible Technical Recovery -- Market Talk

16 mars 2026, 23:05 UTC

Market Talk

Slumping Consumer Confidence Highlights Risk Around RBA Hike -- Market Talk

16 mars 2026, 21:56 UTC

Market Talk

DUG Technology's Stock Fall Creates Opportunity -- Market Talk

16 mars 2026, 21:41 UTC

Market Talk
Principaux Événements d'Actualité

Global Equities Roundup: Market Talk

16 mars 2026, 21:41 UTC

Market Talk
Principaux Événements d'Actualité

Clouds Gather Over Auckland Intl Airport as Airlines Up Fares -- Market Talk

16 mars 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 mars 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 mars 2026, 20:59 UTC

Acquisitions, Fusions, Rachats

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 mars 2026, 20:57 UTC

Acquisitions, Fusions, Rachats

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

16 mars 2026, 20:51 UTC

Acquisitions, Fusions, Rachats

Nvidia-Backed Nscale Plans Huge Data Center Cluster in West Virginia -- WSJ

16 mars 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

16 mars 2026, 20:50 UTC

Market Talk
Principaux Événements d'Actualité

Energy & Utilities Roundup: Market Talk

16 mars 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16 mars 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

16 mars 2026, 19:53 UTC

Principaux Événements d'Actualité

U.S. Allies Rebuff Trump's Demand for Help Opening Strait of Hormuz -- WSJ

16 mars 2026, 19:43 UTC

Market Talk

Global Equities Roundup: Market Talk

16 mars 2026, 19:43 UTC

Market Talk

Nvidia Sees $1 Trillion in Blackwell, Rubin Orders Through 2027 -- Market Talk

16 mars 2026, 19:37 UTC

Market Talk
Principaux Événements d'Actualité

Natural Gas Follows Oil Prices Lower -- Market Talk

16 mars 2026, 19:20 UTC

Principaux Événements d'Actualité

Stock Market Today: Dow Jumps, Brent Crude Pulls Back From $105 -- WSJ

16 mars 2026, 19:17 UTC

Market Talk
Principaux Événements d'Actualité

Crude Oil Sinks on Signals from Strait of Hormuz -- Market Talk

16 mars 2026, 19:00 UTC

Market Talk

Bank of Canada Needs Dovish Approach Based on Weak Data -- Market Talk

16 mars 2026, 18:23 UTC

Market Talk

LME Restarts Trading After Outage -- Market Talk

16 mars 2026, 17:36 UTC

Principaux Événements d'Actualité

Oil Prices Fall as Trump Says Hormuz Help Is Coming. Tankers Getting Through, Bessent Adds. -- Barrons.com

16 mars 2026, 17:19 UTC

Market Talk

Grains Sink as Investors Steer Toward Equities -- Market Talk

16 mars 2026, 17:14 UTC

Principaux Événements d'Actualité

Trump Ends News Conference

Comparaison

Variation de prix

Odonate Therapeutics Inc prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

EBITDA

Bénéfice d'exploitation

$

À Propos Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat